Diagnostics Inc reports results for the quarter ended in January - Earnings Summary

Co-Diagnostics

09/08/2024 12:49

* Co-Diagnostics Inc  CODX.OQ  reported a quarterly adjusted
loss
of 14 cents​​ per share for the quarter ended in January, higher
than the same quarter last year, when the company reported EPS
of -31 cents.  The lone analyst forecast for the quarter was
for a loss of 34 cents per share. 
    * Revenue rose 1,241.9% to $2.66 million from a year ago;
analysts
expected $375.00 thousand. 
    * Co-Diagnostics Inc's reported EPS for the quarter was a
loss
of 25 cents​.
    * The company reported a quarterly loss of $7.6 million.
    * Co-Diagnostics Inc shares had fallen by 18.4% this
quarter and
lost 23.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 54.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "hold"

Wall Street's median 12-month price target for Co-Diagnostics
Inc is $2.00 
This summary was machine generated from LSEG data August 9 at
11:49 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.34          -0.14          Beat
 Mar. 31 2024      -0.21          -0.31          Missed
 Dec. 31 2023      -0.20          -0.50          Missed
 Sep. 30 2023      -0.29          -0.20          Beat